USPTO trademark

ALTAVERE LABS

Opposition periodUSPTOWord markClass 3Class 5Class 10Class 42

"ALTAVERE LABS" is a word mark owned by Altavere Labs, LLC, filed at the USPTO on March 16, 2026. It is in its opposition period and covers classes 3, 5, 10 and 42.

Get this data via the API
Official USPTO record
ALTAVERE LABS trademark as filed
As filed with the USPTO
Status
Opposition period
Since October 6, 2026
Filed
March 16, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99704725
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
4 classes
Ownership

Who owns ALTAVERE LABS

The owner and representative on file with the office.

Owner

Altavere Labs, LLC

Dover, United States

Representative

Scott H. Blackman

Fuller IP Law LLC

Goods and services

What the mark covers

The products and services ALTAVERE LABS is filed for, grouped by Nice class.

  • Toothpaste; Tooth powder; Non-medicated mouthwashes; Non-medicated mouth rinse; Breath freshening preparations for personal hygiene; Tooth whitening preparations; Dental bleaching gel; Preparations for cleaning dentures; Cosmetic preparations for the care of mouth and teeth; Non-medicated body care preparations, namely, creams, lotions, gels, and serums; Non-medicated hair care preparations, namely, shampoos, conditioners, and hair lotions

  • Vaccines; Dietary supplements; Nutritional supplements; Vitamin and mineral supplements; Amino acids for nutritional purposes; Probiotic supplements; Prebiotic supplements; Dietetic foods adapted for medical use; Medicated mouthwash; Medicated dental rinses; Medicated toothpaste; Mouthwashes for medical purposes; Dental varnish for use by dentists; Dental cements; Materials for dental fillings; Dental impression materials; Dental adhesives; Hemostatics for medical purposes; Hemostatics for dental purposes; Dental sealants; Wound dressings; Essential oils for aromatherapy use; Pharmaceutical preparations for the treatment and prevention of oral and oropharyngeal cancers; Pharmaceutical preparations for the treatment and prevention of oral potentially malignant disorders, namely, leukoplakia, erythroplakia, and oral submucous fibrosis; Pharmaceutical preparations for the treatment and prevention of periodontal diseases, namely, gingivitis and periodontitis; Medicated preparations for the treatment and prevention of dental caries; Medicated preparations for the treatment and prevention of oral mucositis; Medicated preparations for the treatment and prevention of oral candidiasis and other fungal infections of the oral cavity; Medicated preparations for the treatment and prevention of medication-related osteonecrosis of the jaw (MRONJ); Medicated preparations for the treatment and prevention of temporomandibular joint disorders; Medicated preparations for the treatment and prevention of xerostomia; Medicated preparations for the treatment and prevention of diabetes and metabolic disorders; Medicated preparations for the treatment and prevention of cardiovascular diseases; Medicated preparations for the treatment and prevention of neurodegenerative diseases; Pharmaceutical preparations for the treatment and prevention of autoimmune and inflammatory conditions; Pharmaceutical preparations for the treatment and prevention of bone and joint disorders, namely, osteoporosis and osteoarthritis; Pharmaceutical preparations for the treatment and prevention of infectious diseases; Pharmaceutical preparations for the treatment and prevention of gastrointestinal disorders; Pharmaceutical preparations for the treatment and prevention of respiratory diseases; Pharmaceutical preparations for the treatment and prevention of dermatological conditions; Pharmaceutical preparations for the treatment and prevention of nutritional deficiencies; Pharmaceutical preparations for the treatment and prevention of pain and inflammation; Pharmaceutical preparations for the treatment and prevention of sleep disorders; Pharmaceutical preparations for the treatment and prevention of anxiety and stress-related conditions; Pharmaceutical preparations for the treatment and prevention of immune system disorders; Pharmaceutical preparations for promoting enamel remineralization and strengthening; Pharmaceutical preparations for the treatment of dentinal hypersensitivity; Pharmaceutical preparations for the promotion of oral wound healing; Pharmaceutical preparations for the management of halitosis; Pharmaceutical preparations for the maintenance of oral microbiome balance; Pharmaceutical preparations for prevention and treatment of peri-implant diseases, namely, peri-implantitis; Pharmaceutical preparations for the support for post-surgical oral tissue recovery; Pharmaceutical preparations for promoting gingival tissue regeneration; Pharmaceutical preparations for the management of oral lichen planus; Pharmaceutical preparations for the management of recurrent aphthous ulcers; Pharmaceutical preparations for tooth whitening and stain prevention; Pharmaceutical preparations for general oral and dental hygiene maintenance

  • Surgical devices and instruments; Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Wearable monitors used to measure biometric data for medical use; Body rehabilitation apparatus for medical purposes; Medical imaging apparatus; Dental implants; Orthodontic appliances; Prosthetic instruments for dental purposes; Endodontic apparatus; Medical apparatus and instruments for use in oral and maxillofacial surgical procedures; Medical apparatus and instruments for use in dental diagnostic and imaging procedures; Medical apparatus and instruments for use in endodontic procedures; Medical apparatus and instruments for use in periodontal procedures; Medical apparatus and instruments for use in orthodontic procedures; Medical apparatus and instruments for use in prosthodontic procedures; Medical apparatus and instruments for use in oral cancer screening and detection; Medical apparatus and instruments for use in biopsy and histopathological specimen collection; Medical apparatus and instruments for use in point-of-care diagnostic testing; Medical apparatus and instruments for use in intraoral and extraoral imaging; Medical apparatus and instruments for use in cephalometric and radiographic analysis; Medical apparatus and instruments for use in salivary diagnostics; Medical apparatus and instruments for use in biosensor-based health monitoring procedures

  • Software as a service (SAAS) services featuring software for use in healthcare and life sciences data analysis; Software as a service (SAAS) services featuring software for clinical decision support; Software as a service (SAAS) services featuring software for analysis of medical images and medical imaging data; Software as a service (SAAS) services featuring software for bioinformatics and computational biology data analysis; Software as a service (SAAS) services featuring software for statistical analysis and simulation tools for drug discovery and molecular design; Software as a service (SAAS) services featuring software for statistical analysis and simulation tools for clinical trial design and optimization; Software as a service (SAAS) services featuring software for electronic health record data analytics; Software as a service (SAAS) services featuring software for remote patient monitoring data analytics; Software as a service (SAAS) services featuring software for medical diagnostic and prognostic analytics; Software as a service (SAAS) services featuring software for genomics and multi-omics data analysis; Providing temporary use of on-line non-downloadable software for managing and analyzing biomedical and clinical research data; Providing temporary use of on-line non-downloadable software for laboratory information management; Application service provider featuring application programming interface (API) software; Design and development of computer software; Computer software consultancy; Cloud computing featuring software for use in healthcare and life sciences data management

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Official gazette publication confirmation e-mailed
  2. Published for opposition
  3. Notification of notice of publication e-mailed
  4. Approved for pub - principal register
  5. Teas/email correspondence entered
  6. Correspondence received in law office
  7. Teas response to office action received
  8. Notification of non-final action e-mailed
  9. Non-final action e-mailed
  10. Non-final action written

5 earlier steps on the official record.

FAQ

About ALTAVERE LABS

Who owns the trademark "ALTAVERE LABS"?

The USPTO trademark "ALTAVERE LABS" (application 99704725) is owned by Altavere Labs, LLC.

What is the status of "ALTAVERE LABS"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ALTAVERE LABS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d3f10-0be2-717b-89dc-ffcc39dee627
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d3f10-0be2-717b-89dc-ffcc39dee627",
  "object": "trademark",
  "mark_text": "ALTAVERE LABS",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "99704725",
  "filing_date": "2026-03-16",
  "nice_classes": [
    3,
    5,
    10,
    42
  ],
  "owners": [
    {
      "name": "ALTAVERE LABS, LLC",
      "entity_id": null
    }
  ]
}